Table S1. IC 50 and Hill coefficient (h) values used as inputs for the 40 in silico drug trials. For each compound, the EFTPC max and TdP risk category are also included. Data come from different sources, and all the references are listed in the table.
1 High TdP Risk: the drug prolongs the QT interval and is clearly associated with a known TdP risk, even when taken as recommended 2 Possible TdP Risk: the drug prolongs the QT interval, but there is a lack of evidence of TdP risk when taken as recommended 3 Conditional TdP Risk: the drug is associated with TdP but only under certain circumstances, e.g. excessive dose or interaction with other drugs 0 No TdP Risk: the drug is not included in any of the CredibleMeds TdP risk categories NC Not Classified: the drug was reviewed by CredibleMeds but the evidence available was not enough to assign it to any of the previous categories 
# Amiodarone
The EFTPC max for Amiodarone was computed by considering C max =2.5 µg/ml 5 and protein binding 96% 6
## Pentamidine
I Kr IC 50 /h for Pentamidine were set based on its effect on hERG trafficking 4 * The EFTPC max for these drugs was computed from their C max 2 and protein binding 6
In silico drug trials for Risperidone were run by considering the active moiety of Risperidone and its 9-OH metabolite (Paliperidone), which also affects cardiac ion channels 13 . 
